QA: TENAX THERAPEUTICS INC. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000034956_2018_TENAX_THERAPEUTICS_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000034956')"}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0000034956, TENAX THERAPEUTICS INC.

  xvar xval
0 AssetsCurrent 8,062,893
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 9,945
3 remainder_Assets 1,817,863
4 LiabilitiesCurrent 1,008,840
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 5,678,581
9 ResearchAndDevelopmentExpense 3,527,317
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 366,216
13 remainder_ComprehensiveNetIncome 17,676,839
  yvar yval
0 Assets 9,890,701
1 Liabilities 1,008,840
2 Expenses 9,205,898
3 Revenues 0
4 StockholdersEquity 8,881,861
5 NetIncome -8,839,682
6 ComprehensiveNetIncome -1,262
7 BaseVar 19,074,247
8 EconomicCapitalRatio 2.80

Edgar->Model Mapping

Feature Distribution

Change over Time